| Literature DB >> 27373153 |
Nan Gu1, Jiyun Peng2, Madhuvika Murugan2, Xi Wang3, Ukpong B Eyo2, Dongming Sun2, Yi Ren4, Emanuel DiCicco-Bloom5, Wise Young2, Hailong Dong6, Long-Jun Wu7.
Abstract
Peripheral nerve injury causes neuropathic pain accompanied by remarkable microgliosis in the spinal cord dorsal horn. However, it is still debated whether infiltrated monocytes contribute to injury-induced expansion of the microglial population. Here, we found that spinal microgliosis predominantly results from local proliferation of resident microglia but not from infiltrating monocytes after spinal nerve transection (SNT) by using two genetic mouse models (CCR2(RFP/+):CX3CR1(GFP/+) and CX3CR1(creER/+):R26(tdTomato/+) mice) as well as specific staining of microglia and macrophages. Pharmacological inhibition of SNT-induced microglial proliferation correlated with attenuated neuropathic pain hypersensitivities. Microglial proliferation is partially controlled by purinergic and fractalkine signaling, as CX3CR1(-/-) and P2Y12(-/-) mice show reduced spinal microglial proliferation and neuropathic pain. These results suggest that local microglial proliferation is the sole source of spinal microgliosis, which represents a potential therapeutic target for neuropathic pain management.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27373153 PMCID: PMC4956495 DOI: 10.1016/j.celrep.2016.06.018
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423